Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorRouillon, Christophe
dc.contributor.authorAthukoralage, Januka S.
dc.contributor.authorGraham, Shirley
dc.contributor.authorGrüschow, Sabine
dc.contributor.authorWhite, Malcolm F.
dc.date.accessioned2018-07-20T16:30:05Z
dc.date.available2018-07-20T16:30:05Z
dc.date.issued2018-07-19
dc.identifier.citationRouillon , C , Athukoralage , J S , Graham , S , Grüschow , S & White , M F 2018 , ' Control of cyclic oligoadenylate synthesis in a type III CRISPR system ' , eLife , vol. 7 , e36734 . https://doi.org/10.7554/eLife.36734en
dc.identifier.issn2050-084X
dc.identifier.otherPURE: 254021822
dc.identifier.otherPURE UUID: 2f818a66-8898-43e6-8cb1-6574d52b3002
dc.identifier.otherWOS: 000439106900001
dc.identifier.otherWOS: 000439106900001
dc.identifier.otherScopus: 85052222007
dc.identifier.otherORCID: /0000-0003-1543-9342/work/47136079
dc.identifier.otherORCID: /0000-0002-1666-0180/work/60427712
dc.identifier.urihttp://hdl.handle.net/10023/15620
dc.descriptionThis work was supported by a grant from the Biotechnology and Biological Sciences Research Council (REF: BB/M000400 /1 to MFW), and a Royal Society Challenge Grant (REF: CH160014 to MFW).en
dc.description.abstractThe CRISPR system for prokaryotic adaptive immunity provides RNA-mediated protection from viruses and mobile genetic elements. When viral RNA transcripts are detected, type III systems adopt an activated state that licenses DNA interference and synthesis of cyclic oligoadenylate (cOA). cOA activates nucleases and transcription factors that orchestrate the antiviral response. We demonstrate that cOA synthesis is subject to tight temporal control, commencing on target RNA binding, and is deactivated rapidly as target RNA is cleaved and dissociates. Mismatches in the target RNA are well tolerated and still activate the cyclase domain, except when located close to the 3' end of the target. Phosphorothioate modification reduces target RNA cleavage and stimulates cOA production. The 'RNA shredding' activity originally ascribed to type III systems may thus be a reflection of an exquisite mechanism for control of the Cas10 subunit, rather than a direct antiviral defence.
dc.format.extent22
dc.language.isoeng
dc.relation.ispartofeLifeen
dc.rights© 2018, Rouillon et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.en
dc.subjectQD Chemistryen
dc.subjectQH301 Biologyen
dc.subjectBiochemistry, Genetics and Molecular Biology(all)en
dc.subjectImmunology and Microbiology(all)en
dc.subjectNeuroscience(all)en
dc.subjectDASen
dc.subjectBDCen
dc.subjectR2Cen
dc.subject.lccQDen
dc.subject.lccQH301en
dc.titleControl of cyclic oligoadenylate synthesis in a type III CRISPR systemen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews.School of Biologyen
dc.contributor.institutionUniversity of St Andrews.Biomedical Sciences Research Complexen
dc.identifier.doihttps://doi.org/10.7554/eLife.36734
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record